33.6 in Aβ-treated group; 56.0% decrease), though this difference did not reach statistical significance ( p > 0.05).
← all excerpts
Ginsenoside Rg3-encapsulated pegylated niosomes exhibit multimodal therapeutic potential in Alzheimer's disease.
1
0.0500
0.0500